News
Despite past setbacks, Aldeyra Therapeutics' history of resilience and upcoming trial results offer potential catalysts for ...
Prodigious siblings can be annoying. All too often, they steal the spotlight and cast behind them an infuriating shadow of ...
The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.
Scientists from Heriot-Watt University have secured new funding to investigate the thermodynamic behaviour of typical carbon ...
Aldeyra (ALDX) announced receipt of a complete response letter from the FDA for the resubmission of the new drug application of reproxalap, an ...
A doctor has warned that a symptom that appears on the face when you drink alcohol could mean you are 80 times more likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results